During the past decade, CNS Research Institute (CRI) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CNS Research Institute (CRI)" are "Anxiety Disorder" (1 trials), "Depressive Disorder, Major" (1 trials), "Major Depressive Disorder" (1 trials) and "Psychotic Disorders" (1 trials). Many other conditions were trialed in "CNS Research Institute (CRI)" in a lesser frequency.

Most popular intervention types in "CNS Research Institute (CRI)" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Mifepristone" (1 trials), "a benzodiazepine drug" (1 trials), "mifepristone" (1 trials), "mifepristone 1200 mg" (1 trials) and "mifepristone 600 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "CNS Research Institute (CRI)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "CNS Research Institute (CRI)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in CNS Research Institute (CRI), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CNS Research Institute (CRI), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".